The week of Chip Ganassi Racing announcements continues with Friday’s confirmation of a multi-year extension with Novo Nordisk, to continue to back Charlie Kimball’s No. 83 Dallara-Chevrolet in the Verizon IndyCar Series.
“Our partnership with Charlie and Chip Ganassi Racing Teams has given us the opportunity to convey that diabetes doesn’t have to keep you from pursuing your dreams, and to inspire those who are working to manage their condition,” Camille Lee, senior vice president, Diabetes Marketing at Novo Nordisk, said in a release. “We couldn’t have picked two better partners to continue that journey.”
Kimball regressed slightly in 2014 from his 2013 heights, when he won his first career race at Mid-Ohio and finished ninth in the championship standings.
However he remains a great ambassador for Novo, and one of IndyCar’s still rising stars at age 29. He continues with CGR for his fifth season in 2015.
“We are very pleased to have Novo Nordisk back with the team as they have been a tremendous partner of ours over the last four years,” said Chip Ganassi, owner of Novo Nordisk Chip Ganassi Racing. “We also expect big things from Charlie as he continues to grow as a driver. We anticipate that 2015 will be a big year for the whole Novo Nordisk racing program.”